Pharmaxis LtdPharmaxis Ltd - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

This page displays a zero-cost ESG assessment for Pharmaxis Ltd. Check the end of the page for potential risks for Pharmaxis Ltd based on industry, geography and marketcap. Other companies in the rating industry group for Pharmaxis Ltd are shown below.

Pharmaxis Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.

SDG Transparency Score for Pharmaxis Ltd 
Low
0 - 3
Medium
4 - 6

8.0

High Impact
7 - 10
Last Score Update: 2023-07-01
What drives the score for Pharmaxis Ltd 
8.0

Environmental

8.0

Social

8.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
36Repligen Corp
8.1
High
36Zealand Pharma A/S
8.1
High
55Pharmaxis Ltd
8.0
High
55Abbott India Ltd
8.0
High
55Amrutanjan Health Care Ltd
8.0
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Pharmaxis Ltd have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Pharmaxis Ltd disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Pharmaxis Ltd report the average age of the workforce?

LockedSign up for free to unlock

Does Pharmaxis Ltd reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Pharmaxis Ltd disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Pharmaxis Ltd disclose cybersecurity risks?

LockedSign up for free to unlock

Does Pharmaxis Ltd offer flexible work?

LockedSign up for free to unlock

Does Pharmaxis Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Pharmaxis Ltd disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Pharmaxis Ltd conduct supply chain audits?

LockedSign up for free to unlock

Does Pharmaxis Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Pharmaxis Ltd conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Pharmaxis Ltd disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Pharmaxis Ltd disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Pharmaxis Ltd disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Pharmaxis Ltd disclose water use targets?

LockedSign up for free to unlock

Does Pharmaxis Ltd have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Pharmaxis Ltd have a product recall in the last two years?

LockedSign up for free to unlock

Does Pharmaxis Ltd disclose incidents of discrimination?

LockedSign up for free to unlock

Does Pharmaxis Ltd allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Pharmaxis Ltd issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Pharmaxis Ltd disclose parental leave metrics?

LockedSign up for free to unlock

Does Pharmaxis Ltd disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Pharmaxis Ltd disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Pharmaxis Ltd disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Pharmaxis Ltd support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Pharmaxis Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Pharmaxis Ltd reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Pharmaxis Ltd involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Pharmaxis Ltd disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Pharmaxis Ltd disclose its waste policy?

LockedSign up for free to unlock

Does Pharmaxis Ltd report according to TCFD requirements?

LockedSign up for free to unlock

Does Pharmaxis Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Pharmaxis Ltd disclose energy use targets?

LockedSign up for free to unlock

Does Pharmaxis Ltd disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Pharmaxis Ltd have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Pharmaxis Ltd
These potential risks are based on the size, segment and geographies of the company.

Pharmaxis Ltd engages in the research, development, and commercialization of healthcare products for the treatment of fibrotic and inflammatory diseases worldwide. The company operates through two segments, Mannitol Respiratory Business and New Drug Development. It offers Bronchitol, an inhaled dry powder for the treatment of cystic fibrosis; and Aridol, an airways inflammation test that is used to identify twitchy or hyper-responsive airways, as well as to assist in diagnosing and managing asthma. The company's product pipeline consists of oral pan-lysyl oxidase inhibitors (LOX) targeting myelofibrosis and other cancers; topical pan-LOX inhibitors targeting skin scarring after events, such as accidents, surgery,and burns; selective Lysyl Oxidase Like Inhibitors (LOXL2) targeting chronic fibrotic diseases, including kidney fibrosis, pulmonary fibrosis, liver fibrosis, and cardiac fibrosis; and semicarbazide-sensitive amine oxidase for neuro inflammatory diseases. It is also developing Orbital, a dry powder inhaler to deliver high drug doses to lungs. Pharmaxis Ltd was incorporated in 1998 and is headquartered in Frenchs Forest, Australia.

Sorry!

Failed to process!